{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T20:03:58Z","timestamp":1773173038224,"version":"3.50.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/mbc.0b013e3283646620","type":"journal-article","created":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T07:21:35Z","timestamp":1382599295000},"page":"74-76","source":"Crossref","is-referenced-by-count":12,"title":["A new case of successful outcome of pregnancy in a carrier of homozygous type II (L99F) antithrombin deficiency"],"prefix":"10.1097","volume":"25","author":[{"given":"Cristina","family":"Pascual","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana R.","family":"Huerta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria P.","family":"Rus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Corral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L.","family":"Diez-Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210203","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1160\/TH07-04-0277","article-title":"Antithrombin: early prophecies and present challenges.","volume":"98","author":"Abildgaard","year":"2007","journal-title":"Thromb Haemost"},{"key":"R2-13-20210203","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1357-2725(03)00244-9","article-title":"Antithrombin: in control of coagulation.","volume":"36","author":"Quinsey","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"R3-13-20210203","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0038-1657549","article-title":"Antithrombin: molecular basis of deficiency.","volume":"78","author":"Bayston","year":"1997","journal-title":"Thromb Haemost"},{"key":"R4-13-20210203","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1172\/JCI10489","article-title":"Complete antithrombin deficiency in mice results in embryonic lethality.","volume":"106","author":"Ishiguro","year":"2000","journal-title":"J Clin Invest"},{"key":"R6-13-20210203","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1182\/blood-2006-08-040774","article-title":"Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis.","volume":"109","author":"Corral","year":"2007","journal-title":"Blood"},{"key":"R7-13-20210203","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1055\/s-0037-1616525","article-title":"Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism.","volume":"86","author":"Kuhle","year":"2001","journal-title":"Thromb Haemost"},{"key":"R8-13-20210203","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.revmed.2009.08.023","article-title":"Antithrombin homozygous type II HBS deficiency (99Leu-Phe) associated with recurrent arterial thrombosis.","volume":"32","author":"Durant","year":"2011","journal-title":"Rev Med Interne"},{"key":"R9-13-20210203","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1182\/blood.V79.5.1206.1206","article-title":"Antithrombin III Budapest: a single amino acid substitution (429 Pro to Leu) in a region highly conserved in the serpin family.","volume":"79","author":"Olds","year":"1992","journal-title":"Blood"},{"key":"R10-13-20210203","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00001721-199610000-00008","article-title":"Homozygous variant of antithrombin with lack of affinity for heparin: management of severe thrombotic complications associated with intrauterine fetal demise.","volume":"7","author":"Bauters","year":"1996","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R11-13-20210203","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1160\/TH07-04-0282","article-title":"Successful outcome in a pregnant woman with homozygous antithrombin deficiency.","volume":"98","author":"Alguel","year":"2007","journal-title":"Thromb Haemost"},{"key":"R12-13-20210203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0038-1655930","article-title":"Antithrombin mutation database: 2nd update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.","volume":"77","author":"Lane","year":"1997","journal-title":"Thromb Haemost"},{"key":"R13-13-20210203","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood-2012-01-406207","article-title":"Role on antithrombin deficiency and thrombotic risk of the beta glycoform: a posttranslational mosaicism for heparin binding mutations.","volume":"120","author":"Martinez-Martinez","year":"2012","journal-title":"Blood"},{"key":"R14-13-20210203","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1447-0756.2001.tb01250.x","article-title":"Management of pregnancy with congenital Antithrombin III deficiency: two case reports and review of the literature.","volume":"27","author":"Yamada","year":"2001","journal-title":"J Obstet Gynecol Res"},{"key":"R15-13-20210203","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1160\/TH08-10-0672","article-title":"Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.","volume":"101","author":"Rodgers","year":"2009","journal-title":"Thromb Haemost"},{"key":"R16-13-20210203","doi-asserted-by":"crossref","first-page":"e691s","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0b013e3283646620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:31:47Z","timestamp":1620959507000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201401000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e3283646620","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}